[The breast cancer screening. do you need to change?].
作者信息
Marzo-Castillejo Mercè
机构信息
Grupo de trabajo sobre el cáncer del Programa de Actividades Preventivas y de Promoción de la Salud de la Sociedad Española de Medicina Familiar y Comunitaria; USR Costa de Ponent, Direcció d'Atenció Primària Metropolitana Sud, IDIAP J. Gol, Cornellà de Llobregat, Barcelona, España.
出版信息
Aten Primaria. 2014 Jun-Jul;46(6):273-5. doi: 10.1016/j.aprim.2014.04.005.
Abstract
摘要
相似文献
1
[The breast cancer screening. do you need to change?].[乳腺癌筛查。你需要改变吗？]
Aten Primaria. 2014 Jun-Jul;46(6):273-5. doi: 10.1016/j.aprim.2014.04.005.
2
Breast cancer: when and how often to get screened. How do you make sense of conflicting mammography guidelines?乳腺癌：何时以及多久进行一次筛查。你如何理解相互矛盾的乳房X光检查指南？
Harv Womens Health Watch. 2013 Oct;21(2):3.
3
Screening mammography for average-risk women.对平均风险女性进行乳腺钼靶筛查。
Menopause. 2018 Mar;25(3):343-345. doi: 10.1097/GME.0000000000001026.
4
Screening mammography and the "r" word.乳腺钼靶筛查与“召回”一词
N Engl J Med. 2009 Dec 24;361(26):2501-3. doi: 10.1056/NEJMp0911447. Epub 2009 Nov 25.
5
"Do unto others as you would have them do unto you": breast imagers' perspectives regarding screening mammography for others and for themselves--do they practice what they preach?“己所不欲，勿施于人”：乳腺成像医师对他人和自身进行筛查性乳房 X 光检查的看法——他们是否言行一致？
AJR Am J Roentgenol. 2015 Jun;204(6):1336-44. doi: 10.2214/AJR.14.13237.
6
On mammography--more agreement than disagreement.在乳腺钼靶检查方面，意见一致之处多于分歧之处。
N Engl J Med. 2009 Dec 24;361(26):2499-501. doi: 10.1056/NEJMp0911288. Epub 2009 Nov 25.
7
Mammogram every 2 years as effective as annual screening.
Lancet Oncol. 2013 Mar;14(3):e93. doi: 10.1016/s1470-2045(13)70040-8.
8
Mammogram debate flares up: Latest breast cancer screening study fuels controversy.乳房X光检查辩论激烈展开：最新的乳腺癌筛查研究引发争议。
Cancer. 2014 Jun 15;120(12):1755-6. doi: 10.1002/cncr.28803.
9
Organised mammographic screening--more benefits than harms.有组织的乳腺钼靶筛查——利大于弊。
Tidsskr Nor Laegeforen. 2013 Mar 19;133(6):619-20. doi: 10.4045/tidsskr.12.0911.
10
Review: Mammography screening reduces breast cancer mortality in women at average risk.综述：乳腺钼靶筛查可降低平均风险女性的乳腺癌死亡率。
Ann Intern Med. 2016 Mar 15;164(6):JC26. doi: 10.7326/ACPJC-2016-164-6-026.
本文引用的文献
1
A systematic assessment of benefits and risks to guide breast cancer screening decisions.系统评估获益与风险以指导乳腺癌筛查决策。
JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398.
2
[GRADE: Methodology for formulating and grading recommendations in clinical practice].[GRADE：临床实践中制定和分级推荐意见的方法]
Aten Primaria. 2015 Jan;47(1):48-55. doi: 10.1016/j.aprim.2013.12.013. Epub 2014 Mar 29.
3
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.25 年随访加拿大国家乳腺癌筛查研究的乳腺癌发病率和死亡率：随机筛查试验。
BMJ. 2014 Feb 11;348:g366. doi: 10.1136/bmj.g366.
4
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.基于风险的乳腺癌筛查策略的成本效益分析和利弊分析。
PLoS One. 2014 Feb 3;9(2):e86858. doi: 10.1371/journal.pone.0086858. eCollection 2014.
5
Quantifying the benefits and harms of screening mammography.定量评估筛查性乳房 X 光检查的益处和危害。
JAMA Intern Med. 2014 Mar;174(3):448-54. doi: 10.1001/jamainternmed.2013.13635.
6
[Supporting the investment in screening].
Gac Sanit. 2013 Jul-Aug;27(4):369-71. doi: 10.1016/j.gaceta.2013.03.008. Epub 2013 May 11.
7
[Cancer prevention recommendations].[癌症预防建议]
Aten Primaria. 2012 Jun;44 Suppl 1(Suppl 1):23-35. doi: 10.1016/S0212-6567(12)70012-4.
8
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件